Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Mariana Oncology

Explore full profile

Delivering innovative, safe and effective radiopharmaceutical care for solid cancers

Woburn, United StatesFounded 2020Biotech & Life Sciences
Valuation $1–2.5B Last recorded · 2024
Headcount <100 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Mariana Oncology and the history behind them.

About Mariana Oncology

Mariana Oncology is a healthcare startup focused on revolutionizing cancer treatment. The company's primary mission is to treat the most challenging solid tumors with safe, effective, and highly targeted therapies, aiming to deliver a superior standard of care. Their client base primarily consists of cancer patients, and they operate in the healthcare and pharmaceutical market.

Mariana Oncology's business model revolves around the development and provision of innovative oncology treatments. They generate revenue through the sale of these treatments to healthcare providers and patients. Additionally, they utilize personal information to enhance service delivery, always ensuring to maintain the highest level of privacy and confidentiality.

The company also creates and uses anonymous data derived from the personal information they collect. This data is used to analyze and improve their services and promote their business. They may also share this anonymous data with third parties for lawful business purposes.

Mariana Oncology operates under strict adherence to United States and foreign intellectual property laws, ensuring that their content and trademarks are protected. They also provide options for users to opt-out of certain data collection practices, ensuring user privacy and data protection.

In conclusion, Mariana Oncology is a promising startup in the healthcare sector, with a strong focus on innovative cancer treatments, data-driven service improvement, and stringent adherence to privacy and intellectual property laws.

Source: Dealroom company data

At a glance

Founded
2020
Headquarters
Woburn, United States
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tier

Investors

14 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A9 investors entered at this stage

Series B and later5 investors entered at this stage

  • Forbion Capital Partners
  • Deep Track Capital
  • Surveyor Capital
  • Eli Lilly
  • Nextech Invest
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Woburn HQ
Book a demo for the full country breakdown
Web traffic by country
2K monthly visits
across markets
🇺🇸 United States100%
Top 1 markets shown

Patents

Estimated portfolio value
$254k

15 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Mariana Oncology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Mariana Oncology on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.